Diagnosis and Treatment of HHV-8–Associated Multicentric Castleman Disease: a Clinical Case From the National Scientific Oncology Center
- 15 December 2025
- journal article
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 1 (2) , onmt012
Abstract
Castleman disease (CD) is a rare lymphoproliferative disorder with heterogeneous clinical manifestations. This article presents a clinical case of HHV-8–associated multicentric Castleman disease (MCD) in an HIV-negative patient treated at the National Scientific Oncology Center. Diagnostic methods included histological and immunohistochemical evaluation, laboratory investigations, and imaging studies. The choice of therapy is discussed. The patient demonstrated resistance to rituximab monotherapy but achieved a favorable response to R-CHOP chemotherapy. This case highlights the importance of early assessment of HHV-8 status and an individualized approach to treatment selection.Keywords
This publication has 2 references indexed in Scilit:
- SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in MedulloblastomaCancers, 2022
- Case 40231New England Journal of Medicine, 1954